statistical analysis of William's Design [Study As­sess­ment]

posted by dshah  – India, 2022-02-18 11:26 (1176 d 06:59 ago) – Posting: # 22797
Views: 4,410

(edited on 2022-02-18 16:27)

Dear Ahmed!

Particularly for EMA as per the guideline: - "In studies with more than two treatment arms (e.g. a three period study including two references, one from EU and another from USA, or a four period study including test and reference in fed and fasted states), the analysis for each comparison should be conducted excluding the data from the treatments that are not relevant for the comparison in question."
So you will need to show the calculations separately.
Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
104 visitors (0 registered, 104 guests [including 6 identified bots]).
Forum time: 19:26 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5